Evidence map›Paper›PMID 27013682›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Agonist-Specific Recruitment of Arrestin Isoforms Differentially Modify Delta Opioid Receptor Function.

Amynah A Pradhan, Julie Perroy, Wendy M Walwyn, Monique L Smith, Ana Vicente-Sanchez, Laura Segura, Alia Bana, Brigitte L Kieffer, Christopher J Evans

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a NovelThe Journal of pharmacology and experimental therapeutics · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Pharmacological reviews · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Opioid-Induced Pronociceptive Signaling in the Gastrointestinal Tract Is Mediated by Delta-Opioid Receptor Signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Negative relationship between brain αExperimental brain research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Amynah A PradhanSemel Institute for Neuropsychiatry and Human Behavior and Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, California 90095, Department of Psychiatry, University of Illinois, Chicago, Illinois 60612, apradhan@psych.uic.edu.
Julie PerroyCentre National de la Recherche Scientifique, Unité Mixte de Recherche-5203, Institut de Génomique Fonctionnelle, Montpellier, F-34094, France, INSERM, U1191, Montpellier, F-34094, France, Universités de Montpellier 1 and 2, Unité Mixte de Recherche-5203, Montpellier, F-34094, France, and.
Wendy M WalwynSemel Institute for Neuropsychiatry and Human Behavior and Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, California 90095.
Monique L SmithSemel Institute for Neuropsychiatry and Human Behavior and Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, California 90095.
Ana Vicente-SanchezDepartment of Psychiatry, University of Illinois, Chicago, Illinois 60612.
Laura SeguraDepartment of Psychiatry, University of Illinois, Chicago, Illinois 60612.ORCID http://orcid.org/0000-0003-3755-8801
Alia BanaSemel Institute for Neuropsychiatry and Human Behavior and Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, California 90095.
Brigitte L KiefferDouglas Hospital, McGill University, Verdun, Quebec H4H 1R3, Canada.
Christopher J EvansSemel Institute for Neuropsychiatry and Human Behavior and Shirley and Stefan Hatos Center for Neuropharmacology, University of California, Los Angeles, California 90095.
University of California, Los Angeles · USUniversity of Illinois Chicago · USDouglas Mental Health University Institute · CAInserm · FR

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIANGDONG WILLIAM · 1987 to 2021
$30.7M
In Vivo Implications of Agonist Selective Activation of Delta Opioid ReceptorR00DA031243 · NIDA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PRADHAN, AMYNAH AMIR ALI · 2013 to 2015
$743k
In Vivo Implications of Agonist Selective Activation of Delta Opioid ReceptorK99DA031243 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRADHAN, AMYNAH AMIR ALI · 2011 to 2012
$317k
NIDA NIH HHS DA031243NIDA NIH HHS DA05010NIDA NIH HHS K99 DA031243NIDA NIH HHS P50 DA005010NIDA NIH HHS R00 DA031243
6 · The paper itself

Abstract

Ligand-specific recruitment of arrestins facilitates functional selectivity of G-protein-coupled receptor signaling. Here, we describe agonist-selective recruitment of different arrestin isoforms to the delta opioid receptor in mice. A high-internalizing delta opioid receptor agonist (SNC80) preferentially recruited arrestin 2 and, in arrestin 2 knock-outs (KOs), we observed a significant increase in the potency of SNC80 to inhibit mechanical hyperalgesia and decreased acute tolerance. In contrast, the low-internalizing delta agonists (ARM390, JNJ20788560) preferentially recruited arrestin 3 with unaltered behavioral effects in arrestin 2 KOs. Surprisingly, arrestin 3 KO revealed an acute tolerance to these low-internalizing agonists, an effect never observed in wild-type animals. Furthermore, we examined delta opioid receptor-Ca(2+)channel coupling in dorsal root ganglia desensitized by ARM390 and the rate of resensitization was correspondingly decreased in arrestin 3 KOs. Live-cell imaging in HEK293 cells revealed that delta opioid receptors are in pre-engaged complexes with arrestin 3 at the cell membrane and that ARM390 strengthens this membrane interaction. The disruption of these complexes in arrestin 3 KOs likely accounts for the altered responses to low-internalizing agonists. Together, our results show agonist-selective recruitment of arrestin isoforms and reveal a novel endogenous role of arrestin 3 as a facilitator of resensitization and an inhibitor of tolerance mechanisms. SIGNIFICANCE STATEMENT: Agonists that bind to the same receptor can produce highly distinct signaling events and arrestins are a major mediator of this ligand bias. Here, we demonstrate that delta opioid receptor agonists differentially recruit arrestin isoforms. We found that the high-internalizing agonist SNC80 preferentially recruits arrestin 2 and knock-out (KO) of this protein results in increased efficacy of SNC80. In contrast, low-internalizing agonists (ARM390 and JNJ20788560) preferentially recruit arrestin 3 and, surprisingly, KO of arrestin 3 produces acute tolerance and impaired receptor resensitization to these agonists. Arrestin 3 is in pre-engaged complexes with the delta opioid receptor at the cell membrane and low-internalizing agonists promote this interaction. This study reveals a novel role for arrestin 3 as a facilitator of receptor resensitization.

Indexed as

Pain PerceptionAnimalsArrestinsBenzamidesDrug ToleranceFemaleHyperalgesiaMaleMiceMice, KnockoutPiperazinesProtein IsoformsReceptors, Opioid, delta4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-N,N-diethylbenzamideArrestinsBenzamidesPiperazinesProtein IsoformsReceptors, Opioid, deltaarrestinDRGGPCRpainresensitizationtolerance

Identifiers

PMID27013682
PMCPMC4804011
OpenAlexW2304807111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.